Metraipolis › archive › dc_3e7990bbb022

Fatal Triple-M Overlap Syndrome After Atezolizumab-Bevacizumab Therapy in Advanced Hepatocellular Carcinoma: A Case Report of Diagnostic Complexity and… — Europe PMC PMID:41978605

Source
Europe PMC (en)
Original
https://europepmc.org/article/MED/41978605
DOI
10.7759/cureus.105174
License (as archived)
solo-consultazione
Archived
2026-11-04T10:05:52.568Z
SHA-256 of the archived text
e8bc5646e7607d4ca86115365c3decc612ea81dcd9c9ed8d0d6be47f4ffe7d68
Stable URL of this page
https://metraipolis.com/documento/dc_3e7990bbb022

How to cite

Fatal Triple-M Overlap Syndrome After Atezolizumab-Bevacizumab Therapy in Advanced Hepatocellular Carcinoma: A Case Report of Diagnostic Complexity and… — Europe PMC PMID:41978605 — Europe PMC (en), https://europepmc.org/article/MED/41978605 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_3e7990bbb022 (Metraipolis archive dc_3e7990bbb022, sha256 e8bc5646e7607d4ca86115365c3decc612ea81dcd9c9ed8d0d6be47f4ffe7d68)
BibTeX
@misc{dc3e7990bbb022,
  title = {Fatal Triple-M Overlap Syndrome After Atezolizumab-Bevacizumab Therapy in Advanced Hepatocellular Carcinoma: A Case Report of Diagnostic Complexity and… — Europe PMC PMID:41978605},
  howpublished = {Europe PMC (en)},
  url = {https://europepmc.org/article/MED/41978605},
  note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_3e7990bbb022; sha256 e8bc5646e7607d4ca86115365c3decc612ea81dcd9c9ed8d0d6be47f4ffe7d68},
  year = {2026}
}

Archived text

The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/41978605. Agents can read the archived copy with the MCP tool read_document.